191 related articles for article (PubMed ID: 8458815)
21. Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure.
Hampl V; Archer SL; Nelson DP; Weir EK
J Appl Physiol (1985); 1993 Oct; 75(4):1748-57. PubMed ID: 7506706
[TBL] [Abstract][Full Text] [Related]
22. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
Chen YF; Feng JA; Li P; Xing D; Zhang Y; Serra R; Ambalavanan N; Majid-Hassan E; Oparil S
J Appl Physiol (1985); 2006 Feb; 100(2):564-71. PubMed ID: 16223981
[TBL] [Abstract][Full Text] [Related]
23. Locus of hypoxic vasoconstriction in isolated ferret lungs.
Brower RG; Gottlieb J; Wise RA; Permutt S; Sylvester JT
J Appl Physiol (1985); 1987 Jul; 63(1):58-65. PubMed ID: 3624150
[TBL] [Abstract][Full Text] [Related]
24. Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m.
Groves BM; Droma T; Sutton JR; McCullough RG; McCullough RE; Zhuang J; Rapmund G; Sun S; Janes C; Moore LG
J Appl Physiol (1985); 1993 Jan; 74(1):312-8. PubMed ID: 8444708
[TBL] [Abstract][Full Text] [Related]
25. Impairment of hypoxic pulmonary artery remodeling by heparin in mice.
Hales CA; Kradin RL; Brandstetter RD; Zhu YJ
Am Rev Respir Dis; 1983 Oct; 128(4):747-51. PubMed ID: 6226226
[TBL] [Abstract][Full Text] [Related]
26. BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats.
Bonvallet ST; Zamora MR; Hasunuma K; Sato K; Hanasato N; Anderson D; Sato K; Stelzner TJ
Am J Physiol; 1994 Apr; 266(4 Pt 2):H1327-31. PubMed ID: 8184910
[TBL] [Abstract][Full Text] [Related]
27. Lung mast cell density and distribution in chronically hypoxic animals.
Tucker A; McMurtry IF; Alexander AF; Reeves JT; Grover RF
J Appl Physiol Respir Environ Exerc Physiol; 1977 Feb; 42(2):174-8. PubMed ID: 138666
[TBL] [Abstract][Full Text] [Related]
28. The pathophysiological basis of chronic hypoxic pulmonary hypertension in the mouse: vasoconstrictor and structural mechanisms contribute equally.
Cahill E; Rowan SC; Sands M; Banahan M; Ryan D; Howell K; McLoughlin P
Exp Physiol; 2012 Jun; 97(6):796-806. PubMed ID: 22366565
[TBL] [Abstract][Full Text] [Related]
29. Comparison of pulmonary vascular function and structure in early and established hypoxic pulmonary hypertension in rats.
Jeffery TK; Wanstall JC
Can J Physiol Pharmacol; 2001 Mar; 79(3):227-37. PubMed ID: 11294599
[TBL] [Abstract][Full Text] [Related]
30. Influence of bronchial arterial PO2 on pulmonary vascular resistance.
Marshall BE; Marshall C; Magno M; Lilagan P; Pietra GG
J Appl Physiol (1985); 1991 Jan; 70(1):405-15. PubMed ID: 2010399
[TBL] [Abstract][Full Text] [Related]
31. Early recovery from hypoxic pulmonary hypertension: a structural and functional study.
Fried R; Reid LM
J Appl Physiol Respir Environ Exerc Physiol; 1984 Oct; 57(4):1247-53. PubMed ID: 6238924
[TBL] [Abstract][Full Text] [Related]
32. Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature.
Berg JT
J Appl Physiol (1985); 2007 Oct; 103(4):1455. PubMed ID: 17916681
[No Abstract] [Full Text] [Related]
33. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
[TBL] [Abstract][Full Text] [Related]
34. A distensible vessel model applied to hypoxic pulmonary vasoconstriction in the neonatal pig.
Nelin LD; Krenz GS; Rickaby DA; Linehan JH; Dawson CA
J Appl Physiol (1985); 1993 May; 74(5):2049-56. PubMed ID: 8335529
[TBL] [Abstract][Full Text] [Related]
35. Time course of the human pulmonary vascular response to 8 hours of isocapnic hypoxia.
Dorrington KL; Clar C; Young JD; Jonas M; Tansley JG; Robbins PA
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1126-34. PubMed ID: 9321798
[TBL] [Abstract][Full Text] [Related]
36. Chronic hypoxia does not cause wall thickening of intra-acinar pulmonary supernumerary arteries.
Oshima K; McLendon JM; Wagner WW; McMurtry IF; Oka M
Physiol Rep; 2016 Feb; 4(2):. PubMed ID: 26811053
[TBL] [Abstract][Full Text] [Related]
37. Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension.
Rochefort GY; Lemaire MC; Eder V; Hanton G; Hyvelin JM; Bonnet P; Antier D
Eur J Pharmacol; 2006 Nov; 550(1-3):149-54. PubMed ID: 17026993
[TBL] [Abstract][Full Text] [Related]
38. Amiloride analogs inhibit chronic hypoxic pulmonary hypertension.
Quinn DA; Du HK; Thompson BT; Hales CA
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1263-8. PubMed ID: 9563749
[TBL] [Abstract][Full Text] [Related]
39. Nitrendipine attenuates the pulmonary vascular remodeling and right ventricular hypertrophy caused by intermittent hypoxia in rats.
Michael JR; Kennedy TP; Buescher P; Farrukh I; Lodato R; Rock PC; Gottlieb J; Gurtner G; de la Monte SM; Hutchins GM
Am Rev Respir Dis; 1986 Mar; 133(3):375-9. PubMed ID: 2937355
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia-induced pulmonary hypertension in an optimized environment for the guineapig.
Bochnowicz S; Osborn RR; Hay DW; Underwood DC
Lab Anim; 1997 Oct; 31(4):347-56. PubMed ID: 9350706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
